global clinical trial consulting LLC

385 fort washington ave #63
new york, new york 10033

NYS Entity Status
ACTIVE

NYS Filing Date
AUGUST 05, 2013

NYS DOS ID#
4440841

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - GLOBAL CLINICAL TRIAL CONSULTING LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Celgene Builds Up Cancer Drug Pipeline With BeiGene Deal
    By Frank Vinluan - Thursday Jul 6, 2017

    Celgene wants a shot at a bigger slice of the global cancer drug market, and the company is turning to China to do it. Summit, NJ-based Celgene has reached a deal with BeiGene, based in Beijing, for rights to a cancer immunotherapy still in clinical trials. The deal announced late Wednesday calls for Celgene (NASDAQ: […]

    Source: Xconomy New York
  • FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths
    By Frank Vinluan - Wednesday Jul 5, 2017

    Nearly a month after Merck paused enrollment in three clinical trials in multiple myeloma to gather more information about patient deaths, the FDA has now put a stop to those studies altogether. Merck (NYSE: MRK) said Wednesday that the FDA has placed a complete hold on two Phase 3 trials testing its immunotherapy drug pembrolizumab […]

    Source: Xconomy New York
  • Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
    By Frank Vinluan - Wednesday Jun 14, 2017

    The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]

    Source: Xconomy New York
  • Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results
    By Frank Vinluan - Wednesday May 31, 2017

    An experimental Teva Pharmaceutical migraine drug has met the main goals of a late-stage clinical trial, keeping the drugmaker in the race to bring to the market a product that prevents migraine headaches instead of treating them after they start. Teva (NYSE: TEVA) reported Wednesday that its drug fremanezumab reduced the number of days during […]

    Source: Xconomy New York
  • Studies Posted On ClinicalTrials.gov Are Not Government-Approved Or Screened
    By Laura Northrup - Thursday Jul 20, 2017

    When facing an illness, you might turn to a clinical trial for treatment that isn’t available eleswhere. The best place for patients to find trials is the site ClinicalTrials.gov, which is a site administered by the National Institutes of Health and is exactly what it sounds like. The site has trials where researchers are testing experimental drugs or procedures that …

    Source: The Consumerist
global clinical trial consulting llc new york ny